Navigation Links
Amgen's Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
Date:1/22/2009

THOUSAND OAKS, Calif., Jan. 22 /PRNewswire-FirstCall/ -- In an ongoing effort to raise awareness of the comprehensive continuum of resources available to cancer patients and their caregivers -- from prevention to education, patient care to advocacy and financial support --Amgen's Breakaway from Cancer(TM) initiative has expanded its charitable partners to now include the National Coalition for Cancer Survivorship, Patient Advocate Foundation, Prevent Cancer Foundation and The Wellness Community.

Amgen created Breakaway from Cancer in 2005 as a complementary component to its sponsorship of the Amgen Tour of California, an annual world-class cycling event that takes place in February. Leading up to and during the nine-day, 750-mile 2009 professional cycling event, which begins in Sacramento on Feb. 14 and ends in Escondido on Feb. 22, multiple Breakaway from Cancer activities will take place to recognize, honor and celebrate cancer survivors.

"One person alone does not beat cancer. It takes a team. Amgen's sponsorship of the Amgen Tour of California provides us with an opportunity to support the millions of people affected by cancer," said Stuart A. Arbuckle, vice president and general manager of Oncology Business Unit at Amgen. "Amgen is proud to work with our Breakaway from Cancer nonprofit partners to raise awareness of the vital programs and services they provide that support people fighting cancer."

All Breakaway from Cancer awareness and fundraising programs will benefit the initiative's four 2009 charitable partners, and representatives of these four organizations will travel with the Amgen Tour of California, hosting a Breakaway from Cancer information booth at the Lifestyle Festival held in each of the finish cities along the route. Additionally, the Lance Armstrong Foundation and Stand Up To Cancer will join forces with the Breakaway from Cancer
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. Novel Technology Breaks Through Cancer Pain
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 27, 2015 , ... This ... industry.The report provides a basic overview of the industry including definitions, classifications, applications ... markets including development trends, competitive landscape analysis, and key regions development status. Development ...
(Date:7/27/2015)... Research presented at the 2015 AACC Annual Meeting & ... led to a fingerprick Ebola test becoming the first ... approval from the World Health Organization (WHO). This test ... West Africa by identifying suspected Ebola ... and treat these patients much faster than is currently ...
(Date:7/27/2015)... -- Junto Health, a company that helps major health ... technology solutions, today announced the launch of a partnership ... health care policy consulting. Working together with SPG, Junto ... process while, at the same time, they are also ... care finance and the delivery of health care services.   ...
(Date:7/25/2015)... (PRWEB) , ... July 25, 2015 , ... ... for its refractometer series. It precisely checks and adjusts the surface temperature of ... measurements. , In the pharmaceutical industry, data traceability and documentation are key requirements. ...
Breaking Biology Technology:2015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4It’s T-Time for Refractometers: On-site Temperature Check Now Available 2
... PCT ... , ... July 13, 2009 -- Progenitor Cell Therapy, LLC (PCT) today announced the recent appointment ... of Manufacturing Operations, Daryl is responsible for managing and supervising the day-to-day conduct of ...
... assistant professor of engineering, has been named one of ... for Scientists and Engineers. The White House named the ... award recognizes outstanding scientists and engineers who, early in ... frontiers of knowledge. It is the highest honor bestowed ...
... , Inc. ("Senesco" or the "Company") (NYSE Amex: ... Company entered into a definitive purchase agreement with Partlet Holdings Ltd. ... of its common stock (the "Shares") at a price of $0.90 ... 1,000,000 shares of common stock, which warrants are exercisable immediately at ...
Cached Biology Technology:Progenitor Cell Therapy Appoints VP of Manufacturing Operations 2Progenitor Cell Therapy Appoints VP of Manufacturing Operations 3Brown engineering professor wins prestigious White House award 2Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing 2Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing 3Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing 4
(Date:6/30/2015)... -- Genisphere announced Tom Bliss ... develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss comes ... of the last 25 years in leadership positions at ... & Johnson. Tom started his career in Investment Banking, ... He graduated from Dartmouth College with a BA in ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
(Date:6/24/2015)... June 24, 2015 Biometry authentication provider ... biometric password solution one face in. ... one face in, entering the expanding biometric ... affordable multifactor-authentication biometric answer to the password problem. ... in partnership with KeyLemon, one face in allows ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3TAKE Solutions Awarded Patent By USPTO 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... in This Edition: , , New hope for tapping vast ... step closer to use in the U. S. , Toward ... , Key proteins identified in the quest for male contraceptive, ... Journalists, Resources: , Press releases, chat room sessions, ...
... today that it has increased its support of high-impact ... Awards to 47 scientists, many of whom are in ... to be up to $138 million over five years, ... transform biomedical and behavioral science. "Nothing is ...
... gut bacteria are thought to be involved in colon cancer ... the USA have discovered that a molecule produced by a ... cancer cells. The research, published in the October issue of ... the way gut bacteria can cause colon cancer. There ...
Cached Biology News:ACS PressPac -- Sept. 17, 2008 2ACS PressPac -- Sept. 17, 2008 3ACS PressPac -- Sept. 17, 2008 4ACS PressPac -- Sept. 17, 2008 5ACS PressPac -- Sept. 17, 2008 6ACS PressPac -- Sept. 17, 2008 7ACS PressPac -- Sept. 17, 2008 8NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 2NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 3NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 4NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 5NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 6NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 7NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 8NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 9Cancer-causing gut bacteria exposed 2
... centrifuge design and manufacturing, Thermo IEC introduces ... (refrigerated) general purpose models provide new conveniences ... Sample Preparation , The CL3 series will ... and has speed and accuracies to the ...
... Molecular Probes intensely fluorescent and highly ... for use in a variety of ... a strong signal. Unfortunately, protein- and ... that may cause them to bind ...
... The Centra-CL5R multi-purpose centrifuge offers both ... large assortment of rotor options, making ... laboratory applications., Maximum Versatility , ... xg) angle rotors or high-volume (4 x ...
... a fully licensed, high throughput, water bath thermal ... to 24 microplates. This equates to 9,216 reactions ... robotic arm rapidly transfers a basket of plates ... times that are considerably faster than those of ...
Biology Products: